secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2026-05-13T12:00:30+00:00
Accession:  0001104659-26-059814
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood CFO Gregory Martini resigns; Ronald Silver named interim CFO
---------------------------------------------------------------------

- Gregory Martini resigns as SVP, CFO effective May 15, 2026, not due to any disagreement with the company on financial reporting.
- Ronald Silver, SVP Corporate Controller and CAO, appointed interim CFO and principal financial officer effective May 15, 2026.
- Silver joined Ironwood in June 2018; served as Corporate Controller and CAO since January 2025.
- Silver is a CPA with prior roles at Eze Software Group and RSM, LLP, and holds a B.S. from U. Maryland and MBA from Georgetown.
- No family relationships with directors/executives; no transactions requiring disclosure under Reg S-K Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465926059814/0001104659-26-059814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465926059814/tm2614428d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-059814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer